168 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 4 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

 

 

RNA tissue category

x

 

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TGM4Transglutaminase 4Cancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Tissue enrichedprostate:688.5
KLK3Kallikrein-related peptidase 3Cancer-related genes
Enzymes
Plasma proteins
Predicted secreted proteins
Tissue enrichedprostate:12913.7
KLK2Kallikrein-related peptidase 2Cancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enrichedprostate:850.1
ACPPAcid phosphatase, prostateCancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enrichedprostate:6368.2
RLN1Relaxin 1Plasma proteins
Predicted secreted proteins
Tissue enrichedprostate:33.4
PRAC1Prostate cancer susceptibility candidate 1Predicted intracellular proteins
Group enrichedcolon:105.4
prostate:197.0
rectum:224.2
KLK4Kallikrein-related peptidase 4Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enrichedprostate:395.8
POTEHPOTE ankyrin domain family, member HPredicted intracellular proteins
Group enrichedprostate:5.7
testis:1.3
MSMBMicroseminoprotein, beta-Cancer-related genes
Disease related genes
Predicted secreted proteins
Tissue enrichedprostate:18712.1
PLA2G4DPhospholipase A2, group IVD (cytosolic)Enzymes
Predicted intracellular proteins
RAS pathway related proteins
Group enrichedprostate:30.0
skin:16.6
SLC45A3Solute carrier family 45, member 3Cancer-related genes
Predicted membrane proteins
Transporters
Nucleoplasm
Vesicles
Tissue enrichedprostate:430.6
CEACAM20Carcinoembryonic antigen-related cell adhesion molecule 20Predicted membrane proteins
Group enrichedduodenum:39.9
prostate:15.5
small intestine:43.6
CHRNA2Cholinergic receptor, nicotinic, alpha 2 (neuronal)Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enrichedprostate:43.0
CDH10Cadherin 10, type 2 (T2-cadherin)Predicted membrane proteins
Group enrichedcerebral cortex:32.7
prostate:6.8
SOX14SRY (sex determining region Y)-box 14Predicted intracellular proteins
Transcription factors
Group enrichedplacenta:2.4
prostate:1.1
CD177CD177 moleculePredicted secreted proteins
Group enrichedbone marrow:193.4
colon:159.0
prostate:110.8
rectum:184.1
NPYNeuropeptide YPlasma proteins
Predicted secreted proteins
Golgi apparatusGroup enrichedadrenal gland:154.2
cerebral cortex:212.3
prostate:448.9
NEFHNeurofilament, heavy polypeptideDisease related genes
Predicted intracellular proteins
Nucleus
Nuclear bodies
Centrosome
Tissue enrichedprostate:484.2
POTEIPOTE ankyrin domain family, member IPredicted intracellular proteins
Group enrichedprostate:18.0
testis:10.4
AP005242.1Predicted membrane proteins
Group enrichedesophagus:4.8
prostate:1.8
NKX3-1NK3 homeobox 1Cancer-related genes
Predicted intracellular proteins
Transcription factors
Tissue enrichedprostate:517.0
RPS4Y2Ribosomal protein S4, Y-linked 2Predicted intracellular proteins
Ribosomal proteins
Group enrichedprostate:3.3
testis:2.2
SLC39A2Solute carrier family 39 (zinc transporter), member 2Predicted membrane proteins
Group enrichedesophagus:19.0
prostate:20.5
seminal vesicle:46.3
skin:34.2
SP8Sp8 transcription factorPredicted intracellular proteins
Transcription factors
NucleusTissue enrichedprostate:9.8
CNTNAP2Contactin associated protein-like 2Disease related genes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Group enrichedcerebral cortex:20.2
prostate:5.7
SRD5A2Steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Group enrichedepididymis:27.4
fallopian tube:31.2
liver:30.6
prostate:25.3
seminal vesicle:24.2
STEAP2STEAP family member 2, metalloreductasePredicted intracellular proteins
Predicted membrane proteins
Transporters
VesiclesTissue enrichedprostate:205.1
NCAPD3Non-SMC condensin II complex, subunit D3Plasma proteins
Predicted intracellular proteins
NucleoplasmTissue enrichedprostate:175.5
GNMTGlycine N-methyltransferaseDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
CytosolGroup enrichedliver:154.6
pancreas:55.8
prostate:34.2
RFPL2Ret finger protein-like 2Predicted intracellular proteins
Nuclear speckles
Plasma membrane
Tissue enrichedprostate:7.0
CPLX3Complexin 3Predicted intracellular proteins
Group enrichedprostate:127.7
spleen:75.8
HOXD13Homeobox D13Cancer-related genes
Disease related genes
Predicted intracellular proteins
Transcription factors
NucleusGroup enrichedcervix, uterine:7.9
colon:5.1
prostate:18.4
rectum:9.6
seminal vesicle:24.4
RDH11Retinol dehydrogenase 11 (all-trans/9-cis/11-cis)Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enrichedprostate:945.5
TRPM8Transient receptor potential cation channel, subfamily M, member 8FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enrichedprostate:128.7
CECR6Cat eye syndrome chromosome region, candidate 6Predicted membrane proteins
Nucleoplasm
Vesicles
Plasma membrane
Group enrichedcerebral cortex:15.0
prostate:10.9
NWD1NACHT and WD repeat domain containing 1Predicted intracellular proteins
Group enrichedcerebral cortex:1.9
fallopian tube:7.6
prostate:5.8
seminal vesicle:1.6
OPRK1Opioid receptor, kappa 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enrichedcerebral cortex:3.6
prostate:3.2
testis:1.8
OR51E2Olfactory receptor, family 51, subfamily E, member 2Cancer-related genes
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enrichedprostate:38.9
RP11-350O14.18Predicted secreted proteins
Group enrichedprostate:14.5
salivary gland:23.2
UPK3AUroplakin 3ADisease related genes
Predicted membrane proteins
Nuclear membrane
Nuclear bodies
Group enrichedparathyroid gland:12.8
prostate:33.5
skeletal muscle:12.6
urinary bladder:16.0
ANO4Anoctamin 4Predicted intracellular proteins
Predicted membrane proteins
Group enrichedadrenal gland:17.6
cerebral cortex:10.0
cervix, uterine:12.5
endometrium:8.3
ovary:10.9
prostate:10.9
seminal vesicle:11.3
CHRM1Cholinergic receptor, muscarinic 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Nucleus
Cytosol
Group enrichedcerebral cortex:40.0
prostate:40.1
salivary gland:11.1
CLVS2Clavesin 2Predicted intracellular proteins
Group enrichedcerebral cortex:15.5
prostate:4.4
COCHCochlinDisease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesGroup enrichedpancreas:94.7
prostate:86.5
seminal vesicle:98.0
COL9A1Collagen, type IX, alpha 1Disease related genes
Predicted secreted proteins
Tissue enrichedprostate:32.7
CRYMCrystallin, muDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
CytosolGroup enrichedcerebral cortex:102.6
heart muscle:98.1
kidney:56.5
prostate:52.7
urinary bladder:30.8
DCXRDicarbonyl/L-xylulose reductaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Nucleoli
Microtubules
Group enrichedepididymis:292.3
kidney:216.4
liver:638.6
prostate:134.3
FOLH1Folate hydrolase (prostate-specific membrane antigen) 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Group enrichedduodenum:307.0
prostate:128.9
small intestine:93.5
LRRC26Leucine rich repeat containing 26Predicted membrane proteins
Plasma membraneGroup enrichedcolon:10.5
prostate:29.3
salivary gland:26.7
SALL4Spalt-like transcription factor 4Disease related genes
Predicted intracellular proteins
Transcription factors
NucleoplasmGroup enrichedparathyroid gland:6.6
prostate:1.4
testis:5.8
thyroid gland:3.5

Page of 4 | next »